← Search recalls
FDA (Device enforcement)Recalled 2020-08-11closedclass ii

Randox Laboratories Ltd.: Lactate Dehydrognease P-L, (UV), Catalog Number LD3818 - Product Usage: device intended for the quantitative in vitro determination of Lactate Dehydrogenase (LD) activity in

Is my product affected?

Lactate Dehydrognease P-L, (UV), Catalog Number LD3818 - Product Usage: device intended for the quantitative in vitro determination of Lactate Dehydrogenase (LD) activity in serum and plasma. This product is suitable for use on the RX series instruments which includes the RX daytona and RX imola.

  • UPC 05055273204117

Check against the official notice below — it lists the full affected range.

What happened

Randox Laboratories Ltd. is updating instructions for its Lactate Dehydrogenase P-L reagent (Catalog Number LD3818), used to measure lactate dehydrogenase activity in blood samples on RX Instruments. The issue involves potential reagent carryover during testing, which could cause inconsistent quality control results or delayed patient sample testing. In some cases, erroneous elevated test results may occur.

Four units of this product with lot number 511979 were distributed nationwide in the United States, including in West Virginia and Puerto Rico. The source document does not specify a remedy or recommended action for affected consumers.

Written by software from the official notice below. Not reviewed by a lawyer.

Hazard

An update to the carryover avoidance technical bulletin to introduce additional steps for reagent carryover avoidance with the Lactate Dehydrogenase assay on RX Instruments. Additional pipette washes can be implemented as described in the technical bulletin. Interference to the Lactate Dehydrogenase (LOH) reagent would be observed as inconsistencies in Quality Control recovery, which may lead to a delay in running patient samples, or erroneous elevated test results.

Details from the source

Reason for recall: An update to the carryover avoidance technical bulletin to introduce additional steps for reagent carryover avoidance with the Lactate Dehydrogenase assay on RX Instruments. Additional pipette washes can be implemented as described in the technical bulletin. Interference to the Lactate Dehydrogenase (LOH) reagent would be observed as inconsistencies in Quality Control recovery, which may lead to a delay in running patient samples, or erroneous elevated test results. Distribution: US Nationwide distribution including in the states of WV, and Puerto Rico. Quantity: 4 Lot/code info: GTIN: 05055273204117; Lot Numbers: 511979

Source

Official record: FDA (Device enforcement) ↗

Republished from the official source above; details can change — the source record controls.

Related recalls

All FDA (Device enforcement) recalls

Hurt by this product? Start a free Case Check

ProductRisk is not a law firm and does not provide legal services or legal advice. ProductRisk is a free consumer product-safety information service operated by Plaintify, Inc., a technology company. If you ask to be connected with a law firm, any legal services are provided by that firm — not by ProductRisk or Plaintify.

Privacy · Plaintify